$VNOV Balance Sheet | Understand Stock

$VNOV

$2.38 +$1.00 (72.46%) Close

$VNOV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited condensed consolidated balance sheets

In USD, except per-share amounts

	Q1 FY2027 As of Jul 31, 2026	Q4 FY2026 As of Apr 30, 2026	Q3 FY2026 As of Jan 31, 2026	Q2 FY2026 As of Oct 31, 2025	Q1 FY2026 As of Jul 31, 2025	Q4 FY2025 As of Apr 30, 2025	Q3 FY2025 As of Jan 31, 2025	Q2 FY2025 As of Oct 31, 2024	Q1 FY2025 As of Jul 31, 2024	Q4 FY2024 As of Apr 30, 2024	Q3 FY2024 As of Jan 31, 2024	Q2 FY2024 As of Oct 31, 2023	Q1 FY2024 As of Jul 31, 2023	Q4 FY2023 As of Apr 30, 2023	Q3 FY2023 As of Jan 31, 2023	Q2 FY2023 As of Oct 31, 2022	Q1 FY2023 As of Jul 31, 2022	Q4 FY2022 As of Apr 30, 2022	Q3 FY2022 As of Jan 31, 2022	Q2 FY2022 As of Oct 31, 2021
Prepayments
Deposit and other receivables
Cash
Accounts receivable, net
Advance to vendors
Prepayment
Inventories
Other current assets
Total current assets
Deferred tax assets
Total noncurrent assets
TOTAL ASSETS
Accrued liabilities and other payables
Amount due to a related party
Accounts payable and accrued expenses
Accounts payable
Deferred revenue
Other current liabilities
Amounts due to related parties
Amount due to a director
Accrued expenses and other current liabilities
Income tax payable
Total current liabilities
TOTAL LIABILITIES
Preferred Stock, $0.001 par value; 10,000,000 shares authorized, including 3,000,000 shares of Series A Preferred Stock designated; nil shares issued and outstanding
Common Stock, $0.001 par value; 200,000,000 shares authorized; 8,337,454 shares issued and outstanding
Additional paid-in capital
Shares to be issued
Retained earnings
Total Shareholders’ Equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Comments